In Vitro Diagnostics Market to Grow by Almost 5% by 2027

The In Vitro Diagnostics Market size is forecast to exceed US$ 85.23 billion by 2027 and the In Vitro Diagnostics market is expected to post a CAGR of close to 5% during the period of 2020 to 2027. The report offers an up-to-date analysis regarding the current market scenario, latest trends and drivers, market share analysis, and the overall market environment.

In recent years, in vitro diagnostics industry has recognized significant developments. Rising geriatric population, prevalence of infectious as well as chronic diseases and existence of automated in vitro diagnosis systems for hospitals to offer precise diagnosis are some of the factors are expected to propel the growth of the market.

A recent study by Precedence Research on the In Vitro Diagnostics market offers a 7-year forecast from 2020 to 2027. The study offers a comprehensive analysis of the current state of the global In Vitro Diagnostics market, as well as projections for overall growth prospects and key factors in major regional markets.

The research report includes a detailed study of regions of North America, Europe, Asia Pacific, and Rest of the World. For these regions, primary variables such as production volume, price analysis, and gross margin analysis are provided. This research report presents the market status, import-export data, and consumption ratio for each region. The SWOT analysis, pricing structures, and gross margin are all analyzed by region.

The report has been curated after observing and studying various factors that determine regional growth such as economic, environmental, social, technological, and political status of the particular region. These analyses will help the reader to understand the potential worth of investment in a particular region.

Get More Information on Various Segments – Request Free Sample PDF

In Vitro Diagnostics Market: Scope

A recent study by Precedence Research on the In Vitro Diagnostics market offers a forecast for 2020 and 2027. The global In Vitro Diagnostics market report covers the following areas:

  • In Vitro Diagnostics Market Size
  • In Vitro Diagnostics Market Share
  • In Vitro Diagnostics Market Growth
  • In Vitro Diagnostics Market Trends
  • In Vitro Diagnostics Market Industry Analysis

Market Sizing and Forecast

There has been a thoughtful approach for estimating the market size and forecast. The primary and secondary research conducted from both, supply and demand side has resulted in high accuracy of data. Logical explanation for the year over year and compound average growth makes it easy for the reader to know the largest revenue generating source and the future potential. The research methodology is a blend of secondary and primary research with more emphasis on the latter. Country level trends were tracked to implement bottom-up method of market size estimation.

Secondary Research

Secondary research occupies approximately 25% of data sources, such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, and so on. This research study includes secondary sources; directories; databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), TRADING ECONOMICS, and avention; Investing News Network; statista; Federal Reserve Economic Data; annual reports; investor presentations; and SEC filings of companies.

Primary Research

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product manufacturers (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.

The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end users (product buyers), and related key executives from various key companies and organizations operating in the global market.

In Vitro Diagnostics Market: Key Players Analysis

The In Vitro Diagnostics market is consolidated with a major number of manufacturers. The company profiling of key players in the market includes major business strategies, company overview and revenues. In-depth interviews and discussions were conducted with several key market participants and opinion leaders to compile the research report. Primary research represents a bulk of research efforts, supplemented by extensive secondary research.

Some of the significant players in the In Vitro Diagnostics market include:

  • Alere, Inc.
  • Hoffmann-La Roche Ltd.
  • Arkray
  • Beckman Coulter
  • Becton Disckinson
  • Bio-Rad laboratories
  • A.
  • Danaher
  • Sysmex Corporation
  • Abbott Laboratories

Segment Analysis

This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Market Segmentation as below:

By Product

  • Reagents
  • Instruments
  • Services

By Technology

  • Hematology
  • Reagents
  • Instruments
  • Service
  • Molecular Diagnostics
  • Reagents
  • Instruments
  • Services
  • Immunology
  • Reagents
  • Instruments
  • Services
  • Coagulation
  • Reagents
  • Instruments
  • Services
  • Clinical Chemistry
  • Reagents
  • Instruments
  • Services
  • Microbiology
  • Reagents
  • Instruments
  • Services
  • Others
  • Reagents
  • Instruments
  • Services

 By Application

  • Diabetes
  • Cardiology
  • Nephrology
  • Infectious Disease
  • Oncology
  • Drug Testing
  • Autoimmune Diseases
  • Others

 By Regional

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • France
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
  • Middle East & Africa
  • Latin America

TABLE OF CONTENT

Chapter 1. Introduction

1.1. Research Objective
1.2. Scope of the Study
1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach
2.2. Data Sources
2.3. Assumptions& Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. In Vitro Diagnostics (IVD) Market Variables and Scope

4.1. Introduction
4.2. Market Classification and Scope

Chapter 5. COVID 19 Impact on In Vitro Diagnostics (IVD) Market

5.1. Covid-19: In Vitro Diagnostics (IVD) Industry Impact
5.2. In Vitro Diagnostics (IVD) Business Impact Assessment: Covid-19
5.2.1. Supply Chain Challenges/Disruption
5.2.2. Market Trends and In Vitro Diagnostics (IVD) Opportunities in the COVID-19 Landscape
5.3. Strategic Measures against Covid-19
5.3.1. Government Support and Initiative to Combat Covid-19
5.3.2. Proposal for In Vitro Diagnostics (IVD) Manufacturers to deal with Covid-19 Pandemic Scenario

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition

Chapter 7. Global In Vitro Diagnostics (IVD) Market: Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis
7.1.1.1. In Vitro Diagnostics (IVD) Market Revenue by Manufacturer (2015-2020)
7.1.1.2. In Vitro Diagnostics (IVD) Market Revenue Market Share by Manufacturer (2015-2020)
7.1.2. Key Organic/Inorganic Strategies Adopted by Players
7.1.2.1. Product Portfolio Expansion, Capacity Expansion, Product Innovation
7.1.2.2. Merger and Acquisition, Collaboration and Partnerships
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers

Chapter 8. Global In Vitro Diagnostics (IVD) Market, By Product Type

8.1. In Vitro Diagnostics (IVD) Market, by Product Type, 2016-2027
8.1.1. Reagents
8.1.1.1. Market Revenue and Forecast (2016-2027)
8.1.2. Instruments
8.1.2.1. Market Revenue and Forecast (2016-2027)
8.1.3. Services
8.1.3.1. Market Revenue and Forecast (2016-2027)

Chapter 9. Global In Vitro Diagnostics (IVD) Market, By Technology

9.1. In Vitro Diagnostics (IVD) Market, By Technology, 2016-2027
9.1.1. Hematology
9.1.1.1. Market Revenue and Forecast (2016-2027)
9.1.2. Molecular Diagnostics
9.1.2.1. Market Revenue and Forecast (2016-2027)
9.1.3. Immunology
9.1.3.1. Market Revenue and Forecast (2016-2027)
9.1.4. Coagulation
9.1.4.1. Market Revenue and Forecast (2016-2027)
9.1.5. Clinical Chemistry
9.1.5.1. Market Revenue and Forecast (2016-2027)
9.1.6. Microbiology
9.1.6.1. Market Revenue and Forecast (2016-2027)
9.1.7. Other
9.1.7.1. Market Revenue and Forecast (2016-2027)

Chapter 10. Global In Vitro Diagnostics (IVD) Market, By Application

10.1. In Vitro Diagnostics (IVD) Market, By Application, 2016-2027
10.1.1. Diabetes
10.1.1.1. Market Revenue and Forecast (2016-2027)
10.1.2. Cardiology
10.1.2.1. Market Revenue and Forecast (2016-2027)
10.1.3. Nephrology
10.1.3.1. Market Revenue and Forecast (2016-2027)
10.1.4. Infectious Disease
10.1.4.1. Market Revenue and Forecast (2016-2027)
10.1.5. Oncology
10.1.5.1. Market Revenue and Forecast (2016-2027)
10.1.6. Drug Testing
10.1.6.1. Market Revenue and Forecast (2016-2027)
10.1.7. Autoimmune Diseases
10.1.7.1. Market Revenue and Forecast (2016-2027)
10.1.8. Others
10.1.8.1. Market Revenue and Forecast (2016-2027)

Chapter 11. Global In Vitro Diagnostics (IVD) Market, Regional Estimates and Trend Forecast

11.1. North America
11.1.1. Market Revenue Forecast by Product (2016-2027)
11.1.2. Market Revenue Forecast By Technology (2016-2027)
11.1.3. Market Revenue Forecast By Application (2016-2027)
11.1.4. Market Revenue Forecast by Technology (2016-2027)
11.1.5. U.S
11.1.5.1. Market Revenue Forecast (2016-2027)
11.1.5.2. Market Revenue Forecast (2016-2027)
11.1.6. Canada
11.1.6.1. Market Revenue Forecast (2016-2027)
11.1.6.2. Market Revenue Forecast (2016-2027)
11.2. Europe
11.2.1. Market Revenue Forecast by Product (2016-2027)
11.2.2. Market Revenue Forecast By Technology (2016-2027)
11.2.3. Market Revenue Forecast By Application (2016-2027)
11.2.4. Market Revenue Forecast by Technology (2016-2027)
11.2.5. UK
11.2.5.1. Market Revenue Forecast (2016-2027)
11.2.5.2. Market Revenue Forecast (2016-2027)
11.2.6. Germany
11.2.6.1. Market Revenue Forecast (2016-2027)
11.2.6.2. Market Revenue Forecast (2016-2027)
11.2.7. France
11.2.7.1. Market Revenue Forecast (2016-2027)
11.2.7.2. Market Revenue Forecast (2016-2027)
11.2.8. Rest of EU
11.2.8.1. Market Revenue Forecast (2016-2027)
11.2.8.2. Market Revenue Forecast (2016-2027)
11.3. Asia Pacific (APAC)
11.3.1. Market Revenue Forecast by Product (2016-2027)
11.3.2. Market Revenue Forecast By Technology (2016-2027)
11.3.3. Market Revenue Forecast By Application (2016-2027)
11.3.4. Market Revenue Forecast by Technology (2016-2027)
11.3.5. China
11.3.5.1. Market Revenue Forecast (2016-2027)
11.3.5.2. Market Revenue Forecast (2016-2027)
11.3.6. India
11.3.6.1. Market Revenue Forecast (2016-2027)
11.3.6.2. Market Revenue Forecast (2016-2027)
11.3.7. Japan
11.3.7.1. Market Revenue Forecast (2016-2027)
11.3.7.2. Market Revenue Forecast (2016-2027)
11.3.8. Rest of APAC
11.3.8.1. Market Revenue Forecast (2016-2027)
11.3.8.2. Market Revenue Forecast (2016-2027)
11.4. LATAM
11.4.1. Market Revenue Forecast by Product (2016-2027)
11.4.2. Market Revenue Forecast By Technology (2016-2027)
11.4.3. Market Revenue Forecast By Application (2016-2027)
11.4.4. Market Revenue Forecast by Technology (2016-2027)
11.4.5. Brazil
11.4.5.1. Market Revenue Forecast (2016-2027)
11.4.5.2. Market Revenue Forecast (2016-2027)
11.4.6. Rest of LATAM
11.4.6.1. Market Revenue Forecast (2016-2027)
11.4.6.2. Market Revenue Forecast (2016-2027)
11.5. Middle East and Africa (MEA)
11.5.1. Market Revenue Forecast by Product (2016-2027)
11.5.2. Market Revenue Forecast By Technology (2016-2027)
11.5.3. Market Revenue Forecast By Application (2016-2027)
11.5.4. Market Revenue Forecast by Technology (2016-2027)
11.5.5. GCC
11.5.5.1. Market Revenue Forecast (2016-2027)
11.5.5.2. Market Revenue Forecast (2016-2027)
11.5.6. North Africa
11.5.6.1. Market Revenue Forecast (2016-2027)
11.5.6.2. Market Revenue Forecast (2016-2027)
11.5.7. South Africa
11.5.7.1. Market Revenue Forecast (2016-2027)
11.5.7.2. Market Revenue Forecast (2016-2027)
11.5.8. Rest of MEA
11.5.8.1. Market Revenue Forecast (2016-2027)
11.5.8.2. Market Revenue Forecast (2016-2027)

Chapter 12. Company Profiles

12.1. Alere, Inc.
12.1.1. Company Overview, Business Information, Manufacturing Area
12.1.2. Product Portfolio Analysis
12.1.2.1. Product Details, Specification, Application
12.1.3. Revenue and Gross Margin (2015-2020)
12.1.4. Recent Developments and Strategies
12.2. Hoffmann-La Roche Ltd.
12.2.1. Company Overview, Business Information, Manufacturing Area
12.2.2. Product Portfolio Analysis
12.2.2.1. Product Details, Specification, Application
12.2.3. Revenue and Gross Margin (2015-2020)
12.2.4. Recent Developments and Strategies
12.3. Arkray
12.3.1. Company Overview, Business Information, Manufacturing Area
12.3.2. Product Portfolio Analysis
12.3.2.1. Product Details, Specification, Application
12.3.3. Revenue and Gross Margin (2015-2020)
12.3.4. Recent Developments and Strategies
12.4. Beckman Coulter
12.4.1. Company Overview, Business Information, Manufacturing Area
12.4.2. Product Portfolio Analysis
12.4.2.1. Product Details, Specification, Application
12.4.3. Revenue and Gross Margin (2015-2020)
12.4.4. Recent Developments and Strategies
12.5. Becton Disckinson
12.5.1. Company Overview, Business Information, Manufacturing Area
12.5.2. Product Portfolio Analysis
12.5.2.1. Product Details, Specification, Application
12.5.3. Revenue and Gross Margin (2015-2020)
12.5.4. Recent Developments and Strategies
12.6. Bio-Rad laboratories
12.6.1. Company Overview, Business Information, Manufacturing Area
12.6.2. Product Portfolio Analysis
12.6.2.1. Product Details, Specification, Application
12.6.3. Revenue and Gross Margin (2015-2020)
12.6.4. Recent Developments and Strategies
12.7. bioMerieux S.A.
12.7.1. Company Overview, Business Information, Manufacturing Area
12.7.2. Product Portfolio Analysis
12.7.2.1. Product Details, Specification, Application
12.7.3. Revenue and Gross Margin (2015-2020)
12.7.4. Recent Developments and Strategies
12.8. Danaher
12.8.1. Company Overview, Business Information, Manufacturing Area
12.8.2. Product Portfolio Analysis
12.8.2.1. Product Details, Specification, Application
12.8.3. Revenue and Gross Margin (2015-2020)
12.8.4. Recent Developments and Strategies
12.9. Sysmex Corporation
12.9.1. Company Overview, Business Information, Manufacturing Area
12.9.2. Product Portfolio Analysis
12.9.2.1. Product Details, Specification, Application
12.9.3. Revenue and Gross Margin (2015-2020)
12.9.4. Recent Developments and Strategies
12.10. Abbott Laboratories
12.10.1. Company Overview, Business Information, Manufacturing Area
12.10.2. Product Portfolio Analysis
12.10.2.1. Product Details, Specification, Application
12.10.3. Revenue and Gross Margin (2015-2020)
12.10.4. Recent Developments and Strategies
12.11. Company 11
12.11.1. Company Overview, Business Information, Manufacturing Area
12.11.2. Product Portfolio Analysis
12.11.2.1. Product Details, Specification, Application
12.11.3. Revenue and Gross Margin (2015-2020)
12.11.4. Recent Developments and Strategies
12.12. Company 12
12.12.1. Company Overview, Business Information, Manufacturing Area
12.12.2. Product Portfolio Analysis
12.12.2.1. Product Details, Specification, Application
12.12.3. Revenue and Gross Margin (2015-2020)
12.12.4. Recent Developments and Strategies

Chapter 13. Research Methodology

13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions

Chapter 14. Appendix

14.1. About Us
14.2. Glossary of Terms

PURCHASE THIS EXCLUSIVE RESEARCH [email protected] https://www.precedenceresearch.com/checkout/1130

About Us:

Precedence Research is a worldwide market research and consulting organization. We give unmatched nature of offering to our customers present all around the globe across industry verticals. Precedence Research has expertise in giving deep-dive market insight along with market intelligence to our customers spread crosswise over various undertakings. We are obliged to serve our different client base present over the enterprises of medicinal services, healthcare, innovation, next-gen technologies, semi-conductors, chemicals, automotive, and among different ventures present globally.

Contact Us:

Mr. Alex

Sales Manager

Call: +1 9197 992 333

Email: [email protected]

Blog: https://precedenceresearchnews.wordpress.com

Leave a comment

Your email address will not be published. Required fields are marked *